Spirolactam aryl CGRP receptor antagonists

Details for Australian Patent Application No. 2006316627 (hide)

Owner Merck & Co., Inc.

Inventors Bell, Ian M.; Zartman, C. Blair; Gallicchio, Steven N.; Stump, Craig A.; Theberge, Cory R.; Wood, Michael R.; Selnick, Harold G.

Agent Spruson & Ferguson

Pub. Number AU-A-2006316627

PCT Pub. Number WO2007/061677

Priority 60/737,976 18.11.05 US

Filing date 14 November 2006

Wipo publication date 31 May 2007

International Classifications

A01N 43/42 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/061677 Priority application(s): WO2007/061677

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316629-Humanized immunoglobulin reactive with alpha 4 beta 7 integrin

2006316626-Spirohydantoin aryl CGRP receptor antagonists